Artivion | CRY - Cost Of Sales

Stock Price
22.77
Daily Change
-0.16 -0.70%
Monthly
-38.02%
Yearly
-22.84%
Q2 Forecast
24.88

Artivion reported $42.85M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Abbott USD 5.3B 380M Mar/2026
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 37.29M 786K Sep/2025
Artivion USD 42.85M 3.86M Dec/2025
AtriCure USD 31.94M 3.22M Mar/2026
Baxter International USD 1.81B 587M Mar/2026
Becton, Dickinson and Co. USD 2.56B 281M Mar/2026
Boston Scientific USD 1.83B 8M Mar/2026
Edwards Lifesciences USD 362.6M 19.6M Mar/2026
Inogen USD 39.59M 1.27M Sep/2024
Integra LifeSciences USD 178.71M 14.73M Mar/2026
J&J USD 8.07B 103M Mar/2026
Mesa Laboratories USD 21.92M 1.78M Sep/2024
Orthofix International USD 66.63M 6.4M Dec/2025
Pfizer USD 4.59B 1.7B Mar/2026
ResMed USD 551.67M 4.17M Mar/2026
Stryker USD 2.36B 325M Mar/2026
Surmodics USD 9.49M 23.54M Jun/2025
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 240.84M 20.7M Mar/2026
Terumo JPY 143.44B 15.47B Dec/2025
Trinity Biotech USD 7.84M 3.14M Sep/2025